Evaluation of Glycated Hemoglobin (HbA1c) for Diagnosing Type 2 Diabetes and Prediabetes among Palestinian Arab Population by Kharroubi, Akram T. et al.
Evaluation of Glycated Hemoglobin (HbA1c) for
Diagnosing Type 2 Diabetes and Prediabetes among
Palestinian Arab Population
Akram T. Kharroubi1*, Hisham M. Darwish2, Ahmad I. Abu Al-Halaweh3, Umaiyeh M. Khammash4
1Department of Medical Laboratory Sciences, Faculty of Health Professions, Al-Quds University, Jerusalem, Palestine, 2 Faculty of Medicine, Molecular Genetics
Laboratory, Al Quds University, Jerusalem, Palestine, 3Augusta Victoria Hospital, Jerusalem, Palestine, 4United Nation Relief and Working Agency (UNRWA), Jerusalem,
Palestine
Abstract
The purpose of the study is to compare the potential of HbA1c to diagnose diabetes among Palestinian Arabs compared to
fasting plasma glucose (FPG). A cross-sectional sample of 1370 Palestinian men (468) and women (902) without known
diabetes and above the age of 30 years were recruited. Whole blood was used to estimate HbA1c and plasma for FPG and
total lipid profile. Fasting plasma glucose was used as a reference to diagnose diabetes ($ 126 mg/dL) and prediabetes
(100–125 mg/dL). The area under the receiver operating characteristic curve (AUC) for HbA1c was 81.9% to diagnose
diabetes and 63.9% for prediabetes. The agreement between HbA1c and diabetes as diagnosed by FPG was moderate (K =
0.498) and low with prediabetes (K= 0.142). The optimal cut-off value for HbA1c to diagnose diabetes was $ 6.3%
(45 mmol/mol). The sensitivity, specificity and the discriminant ability were 65.6% (53.1–76.3%), 94.5% (93.1–95.6%), 80.0%
(72.8–87.3%), respectively. However, using cut-off value of$ 6.5% (48 mmol/mol) improved specificity. At this cut-off value,
the sensitivity, specificity and the discriminant ability were 57.4% (44.9–69.0%), 97.1% (96.0–97.9%) and 77.3% (71.0–83.5%).
For diagnosing prediabetes with HbA1c between 5.7–6.4% (39–46 mmol/mol), the sensitivity, specificity and the
discriminant ability were 62.7% (57.1–67.9%), 56.3% (53.1–59.4%) and 59.5% (56.3–62.5%), respectively. HbA1c at cut-off
value of $ 6.5% (48 mmol/mol) by itself diagnosed 5.3% and 48.3% as having diabetes and prediabetes compared to 4.5%
and 24.2% using FPG, respectively. Mean HbA1c and FPG increase significantly with increasing body mass index. In
conclusion, the ROC curves showed HbA1c could be used for diagnosing diabetes when compared to FPG but not for
prediabetes in Palestinians Arabs even though only about 50% of the diabetic subjects were identified by the both HbA1c
and FPG.
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Introduction
The Center for Disease Control (CDC) reported a world-wide
prevalence of diabetes in its national diabetes fact sheet to be
11.57% [1]. According to Hare et al. [2], diabetes mellitus is the
greatest public threat of the 21st Century with currently 285
million people world-side having diabetes and is expected to
double to 439 million by 2030 with an additional half billion
people are expected to be at high risk. These are conservative
figures since, on one hand, type 2 diabetes mellitus is spreading
among the young generation due to changes in their life style all
over the world and, on the other hand, new diagnostic criteria of
diabetes mellitus using HbA1c is emphasizing specificity over
sensitivity as recommended by the International Expert Commit-
tee [3] which may underestimates the prevalence of diabetes [4].
Since the recommendation of the International Expert Com-
mittee in 2009 to use HbA1c test to diagnose diabetes [3], the
American Diabetes Association (ADA), the Endocrine Society [5],
the Word Health Organization [6] and most scientists in different
countries all over the world have endorsed using HbA1c to
diagnose diabetes. The advantages of using HbA1c over fasting
plasma glucose (FPG) to diagnose diabetes include greater
convenience and preanalytical stability, lower CV (3.6%) com-
pared to FPG (5.7%) and 2h – Oral Glucose Tolerance Test
(OGTT) (16.6%). Stronger correlation with microvascular com-
plications especially retinopathy, a marker for glycemic control
and glycation of proteins is the direct link between diagnosis of
diabetes and its complications [7–12].
Most studies with different ethnic groups have endorsed a cut-
off value for an HbA1c of $ 6.5% (48 mmol/mol) to diagnose
diabetes as has been recommended by the International Expert
Committee [3]. The ADA considers people to be at high risk
(prediabetes) if HbA1c is 5.7–6.4% (39–46 mmol/mol) [4].
Different cut-off values have been reported for diagnosing diabetes
in different ethnic groups and ethnicity seems to have a strong
influence on cut-off values to diagnose diabetes [13,14]. Cut-off
values of 5.5% (37 mmol/mol) [15]; 6.5% (48 mmol/mol) [16]
have been reported in a Japanese studies, 6.0% (42 mmol/mol) in
National Health and Nutrition Examination Survey (NHANES
III), 6.2% (44 mmol/mol) in a Pima Indian study, 6.3%
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(45 mmol/mol) in an Egyptian study as reported by Davidson [8];
and three cut-off values for Chinese [14]. The Australians
recommended the use of two cut-off values; # 5.5% to ‘rule-out’
and $ 7.0% to ‘rule-in’ diabetes [17]. Variations in prevalence of
diabetes [18–22] and prediabetes [23] due to ethnicity have been
documented.
Evaluating the cut-off value for diagnosing diabetes using
HbA1c in Arabs needs to be investigated. One report investigated
adult Arabs living in Detroit, USA [24] and another one from Abu
Dhabi, United Arab Emirates [25]. This is the first report on using
HbA1c to diagnose diabetes in adult Palestinians living in, and in
the neighborhood of, the refugee camps in the center and southern
locations of the West Bank region in Palestine.
Materials and Methods
Ethics Statement
Ethical approval for the study protocol was obtained from the
Research Ethics Committee of Al-Quds University in the
Palestine. Written informed consent was obtained from all
participants involved in the study.
Participants
A convenient cross-sectional sample of 1370 adult Palestinian
men (468) and women (902) without known diabetes and above
the age of 30 years were recruited (based on their volunteer
attendance to clinics) from central and southern refugee camps in
Ramallah, Bethlehem and Hebron districts administered by
UNRWA. All subjected were instructed to fast for 10–12 hours
before coming to the clinic at 8:00 am. A special questionnaire
concerning family history and health-related information was filled
for all participants by direct interviews with the researchers. People
previously diagnosed with diabetes or hemoglobinopathies were
ruled out from the study. Blood samples were collected from all
subjects using EDTA tubes and centrally analyzed for HbA1c.
Plasma was also used to analyze FPG and total lipid profile, total
cholesterol (TC), triglycerides (TG), high-density lipoprotein
(HDL) and low-density lipoprotein (LDL). Blood pressure (BP)
and BMI were also measured by the medical staff in the clinics.
Body mass index (BMI) in kg/m2 was categorized as normal (BMI
, 25), overweight (BMI $ 25 to , 30) and obese (BMI $ 30).
The cut-off values for diabetes using FPG was $ 126 mg/dL,
prediabetes 100–125 mg/dL and normal subjects having FPG ,
100 mg/dL. Specificity, sensitivity, and the area under the ROC
curve (AUC) for HbA1c using different cut-off values were
calculated using FPG as the ‘‘gold standard’’.
Analytical procedures
Blood samples were tested for FPG, HbA1c, total lipid profile
including TC, TG, LDL, and HDL. Fasting plasma glucose and
total lipid profile (TC, TG, HDL) were measured enzymatically
using Chemwell chemistry analyzer (Awareness Tech, USA),
LDL- cholesterol (C) was calculated from the equation of
Friedewald equation (LDL–C = TC – [HDL–C + (TG/5)]).
HbA1c was measured using 3 mL EDTA blood by ion-exchange
HPLC using TOSOH G8. Hemoglobin levels and CBC were
measured for anemia evaluation as well hemoglobin variants were
analyzed because of their interference with HbA1c levels. HbA1c
assay was standardized to the Diabetes Control and Complications
Trial (DCCT) assay method.
Statistical analysis
Statistical analysis was performed using SPSS 17.0 software
(SPSS Inc., Chicago, IL, USA). Pearson’s correlation coefficient
was used to test for co-linearity between the continuous variables,
statistical comparisons between different groups for these contin-
uous variables were carried out using Student’s t test and
ANOVA. Pearson’s Chi-Square statistic was used to assess for
relationships between categorical variables. Receiver operating
characteristic (ROC) curves were constructed to calculate sensi-
tivity, specificity, predictive value positive (PVP) and predictive
value negative (PVN) at different cut-off values for HbA1c. Kappa
(K) coefficients were used to test for agreement between HbA1c and
diabetes status based on FPG levels (diabetes and prediabetes).
The ROC curve plots the sensitivity against 1 minus the specificity
at all possible HbA1c cut-off values. The higher the AUC, the
better the predictive value of HbA1c based on the logistic
regression model. An AUC value of 0.5 would indicate no
predictive value, whereas a value of 1.0 would indicate perfect
predictive value with no false positives or false negatives.
Sensitivity at each possible HbA1c cut-off value was calculated
as [TP/(TP +FN)] X 100, where TP = true positive (diabetic FPG
and HbA1c cut-off value) and FN = false negative (diabetic FPG,
# cut-off value for HbA1c). The sensitivity represents the
percentage of those with fasting plasma glucose , 126 mg/dL
(7.0 mmol/L) who are classified as positive according to HbA1c.
Specificity was calculated as [TN/(TN + FP)] X 100, where TN
= true negative (non-diabetic FPG and# cut-off value for HbA1c)
and FP = false positive (nondiabetic FPG, . cut-off value for
HbA1c). The specificity represents and percentage of those with
FPG , 126 mg/dL (7.0 mmol/L) who are classified as negative
according to the HbA1c. Youdin index and the discriminant
ability at each cut-off value for HbA1c were used to determine the
optimal cut-off value for HbA1c to diagnose diabetes. The
discriminant ability is the average of sensitivity and specificity at
each cut-off value. Venn diagrams were used for visual display or
concordance/ discordance between FPG and HbA1c-based
classification of participants. Statistical significance was accepted
at p,0.05. Because of missing values the number of each group in
different comparisons is different.
Results
Fifty percent of the subjects that participated in this study were
between the age of 40–49 years. They had no previous diagnosis of
diabetes, but 56% of them had a family history of diabetes. The
percentage of subjects with hypertension defined as systolic BP $
120 mmHg or diastolic BP $ 90 mmHg was about 5.1 and 6.1,
respectively. The percentage of subjects with High TC ($
5.5 mmol/L), TG ($ 2.0 mmol/L) and LDL ($ 3.5 mmol/L)
was 16.2%, 15.4% and 27.1% respectively; whereas the percent-
age of subjects with high HDL ($ 2.0 mmol/L) were 36.8%. The
mean values of age, FPG, HbA1c, TC, LDL were not significantly
different between males and females whereas mean values of
systolic BP, diastolic BP, and TG were significantly higher
(p,0.001) in males compared to females and mean HDL and
BMI were significantly higher (p,0.001) in females compared to
males using t test to compare means.
Figure 1 shows the ROC curves for HbA1c using FPG as a
reference. The area under the ROC curve is 0.819 (0.75–0.89) for
diagnosing diabetes (Figure 1 A) and 0.639 (0.60–0.68) for
prediabetes (Figure 1 B). The agreement between HbA1c and
diabetes was moderate (K=0.498) and low with prediabetes
(K=0.142). The cut-off value of equal sensitivity and specificity or
the closest point to 100% sensitivity for diagnosing diabetes was
about 5.9% (41 mmol/mol).
Different cut-off values were tested for their ability to diagnose
diabetes using FPG as the gold standard. Table 1 shows that
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HbA1c with cut-off value of $ 6.3% (45 mmol/mol) has the
highest discriminant ability (80.0%) with sensitivity of 65.6% and
specificity of 94.5%, Youden index also gave an optimum cut-off
value of $6.3. A cut-off value of $ 6.5% (48 mmol/mol) gave a
specificity of 97.1% and a reasonable sensitivity (57.4%). However,
a cut-off value of $ 5.9% (41mmol/mol) gave a specificity of
71.1% and a sensitivity of 75.4%. Lower cut-off values less than
5.9% (41mmol/mol) gave poor specificity. The percentage of
subjects diagnosed as having diabetes using FPG ($ 126 mg/dL)
and HbA1c at cut-off values of 6.5% (48 mmol/mol), 6.3%
(45 mmol/mol), and 5.9% (41 mmol/mol) were 4.5%, 5.3%,
8.2%, and 30.4%, respectively.
From a total of 1370 subjects, 61 (4.5%) were diagnosed with
diabetes using the criteria of FPG ($ 126 mg/dL) and 73 (5.3%)
were diagnosed having diabetes using the criteria of HbA1c $
6.5% (48 mmol/mol). Thirty five subject were diagnosed with
diabetes (2.6%) having both criteria. Thirty eight subjects (2.8%)
were diagnosed to have diabetes by HbA1c but not by FPG criteria
whereas 26 subjects (1.9%) were diagnosed to have diabetes by
FPG but not HbA1c criteria. At a cut-off value of $ 6.5%
(48 mmol/mol) HbA1c diagnosed 57.4% of subjects to have
diabetes from those diagnosed by FPG ($ 126mg/dL), whereas
HbA1c diagnosed 55.8% of subjects to be normal (, 5.7%,
39 mmol/mol) from those diagnosed by FPG (,100 mg/dL). On
the other hand, HbA1c diagnosed 628 (45.8%) as having
prediabetes (5.7–6.4%, 39–46 mmol/mol) compared to 337
(24.6%) by FPG (100–125 mg/dL), 193 (14.1%) met both criteria.
The Venn diagrams for diabetes using ADA classification
criteria are shown in Figure 2. Only 35.4% of subjects with
diabetes meet both FPG and HbA1c criteria whereas 38.4% are
diagnosed by HbA1c only and 26.3% by FPG only. In prediabetes
Figure 2 shows that only 26.5% have prediabetes with both FPG
and HbA1c criteria whereas HbA1c diagnosed 57.8% and FPG
diagnosed 15.8%. Approximately 50% of normal subjects are
diagnosed by both HbA1c and FPG, however, only 11.6% are
diagnosed normal by HbA1c and not by FPG and 39.1% are
diagnosed normal by FPG and not by HbA1c.
Figure 1. HbA1c receiver operating characteristic (ROC) curves for diabetes (A) and prediabetes (B) using FPG as a reference. AUC:
area under the receiver operating characteristic curve.
doi:10.1371/journal.pone.0088123.g001
Table 1. The effect of different cut-off values of HbA1c on sensitivity, specificity, PVP, PVN, percent of diabetes and area under ROC
curves using FPG to diagnose diabetes (cut-off value $126 mg/dL).
Cut-off Sensitivity Specificity PVP PVN Diabetes Discriminant
value % % % % % Ability (%){
$ 5.5 (37) 91.8 30.1 5.8 98.7 70.9 60.9
$ 5.6 (38) 83.6 40.3 6.1 98.1 60.8 61.9
$ 5.7 (39) 80.3 50.2 7.0 98.2 51.2 65.3
$ 5.8 (40) 78.7 61.3 8.6 98.4 40.5 70.0
$ 5.9 (41) 75.4 71.1 11.1 98.4 30.4 73.3
$ 6.0 (42) 72.1 81.6 15.4 98.4 20.8 76.8
$ 6.1 (43) 70.5 87.9 21.3 98.5 14.7 79.2
$ 6.2 (44) 67.2 91.7 27.5 98.4 10.9 79.5
$ 6.3 (45)` 65.6 94.5 35.7 98.3 8.2 80.0
$ 6.4 (46) 62.3 96.0 42.2 98.2 6.6 79.1
$ 6.5 (48) 57.4 97.1 47.9 98.0 5.3 77.3
$ 7.0 (53) 42.6 99.2 72.1 97.4 2.6 70.9
$ 8.0 (64) 27.9 99.6 77.3 96.7 1.6 63.7
HbA1c values are % (mmol/mol); PVP: Predictive value positive; PVN: predictive value negative; ROC: Receiver operating characteristics; AUC: Area under ROC curve.
{Discriminant ability = (sensitivity +specificity)/2. `Highest discriminant ability seen for HbA1c of 6.3%.
doi:10.1371/journal.pone.0088123.t001
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Table 2 shows that all of the parameters measured (age, systolic
BP, Diastolic BP, FPG, HbA1c, TC, TG, LDL and BMI) were
significantly higher in subjects with diabetes compared to controls
using the criteria of FPG ($ 126 mg/dL) or HbA1c ($ 6.5%
48 mmol/mol) to diagnose diabetes except for HDL where the
difference between the means was not significant. Other HbA1c
cut-off values tested such as 5.5% (37 mmol/mol), 6.0%
(42 mmol/mol) and 7.0% (53 mmol/mol) also gave similar
differences using t-test to compare means (data not shown).
Pearson correlation coefficients assessed between parameters
measured in all recruited subjects were significant (p,0.01)
between age and both FPG (r = 0.146) and HbA1c (r = 0.259),
FPG and HbA1c, TC, TG, LDL and BMI (r = 0.584, 0.242, 0.294,
0.135 and 0.133, respectively). HbA1c correlations with the above
parameters were also similar (r = 0.129, 0.124, 0.111 and 0.166
for TC, TG, LDL and BMI, respectively).
Approximately 47% of the subjects were obese (BMI $ 30).
Mean comparisons by ANOVA of both HbA1c and FPG in obese
subjects increase slightly (5 and 8%, respectively) but significantly
(p,0.05) compared to normal subjects (BMI , 25). On the other
hand, mean BMI values are significantly higher in diabetes
compared to normal subjects based on FPG cut-off value of
126 mg/dL (32.5 vs. 29.7 respectively, p,0.001). There is also a
similar increase in mean values of HbA1c and FPG in overweight
subjects (BMI 25 to , 30) compared to normal subjects (5.7%,
39 mmol/mol vs. 5.5%, 37 mmol/mol, respectively, for HbA1c
and 5.29 vs. 5.07 mmol/L, respectively, for FPG). Table 3 shows
that diabetic and cardiovascular risk factors were nearly the same
whether subjects were diagnosed by HbA1c or FPG or both. The
only difference among tested parameters was the TC where the
number of diabetic subjects diagnosed by HbA1c or both FPG and
HbA1c was statistically higher than those diagnosed by FPG.
Discussion
This study demonstrated the feasibility of using HbA1c in
Palestinian Arabs to diagnose diabetes with area under the ROC
curve of 0.819. The ideal cut-off value from the ROC curve was
approximately 5.9% (equal sensitivity and specificity), however, the
optimal cut-off value with the highest discriminant ability was 6.3%.
Figure 2. Venn Diagrams for Diabetes, ADA standards. Diabetes diagnosed by HbA1c $ 6.5% (48 mmol/mol, n = 73) or FPG $ 126 mg/dL
(n = 61). Prediabetes diagnosed by HbA1c 5.7–6.4% (39–46 mmol/mol, n = 628) or FPG 100–125 mg/dL (n = 337). Normal diagnosed by HbA1c , 5.7%
(39 mmol/mol, n = 669) or FPG ,100 mg/dL (n = 972).
doi:10.1371/journal.pone.0088123.g002
Table 2. The difference between mean values of measured parameters between subjects with diabetes vs. normal subjects
according to FPG and HbA1c criteria.
Parameter Mean ± STD Mean ± STD
Normal by Diabetes by p Normal by Diabetes by p
FPG FPG value HbA1c HbA1c value
Age 44.967.29 49.367.60 .001 44.867.26 50.367.34 .001
Systolic BP 116613.3 123613.7 .001 116613.3 125612.8 .001
Diastolic BP 74.269.14 77.568.87 .006 74.069.11 79.268.53 .001
FPG mmol/L 5.166.66 9.5263.22 .001 5.216.98 7.8062.83 .001
HbA1c % ( 5.76.44 7.362.02 .001 5.66.36 7.761.63 .001
TC mmol/L 4.586.96 5.3861.64 .001 4.6061.01 4.916.96 .009
TG mmol/L 1.326.82 2.3862.35 .001 1.356.96 1.8161.06 .001
HDL mmol/dL .946.27 .936.30 .823 .946.27 .916.21 .437
LDL mmol/L 3.056.79 3.336.85 .008 3.056.80 3.246.72 .047
BMI 30.265.57 32.565.57 .002 30.265.56 32.865.62 .001
Diagnosed by FPG (cut-off value $126 mg/dL): N for diabetes = 61, N for normal = 1309
Diagnosed by HbA1c (cut-off value $6.5%), N for diabetes = 73, N for normal = 1297
t test was used to compare means of diabetes vs. control.
doi:10.1371/journal.pone.0088123.t002
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This cut-off value is in agreement with the study on Abu Dhabi
Arab population of the United Arab Emirates, UAE, [_EN-
REF_2525] which reported a cut-off value of 6.4%. At cut-off value
of $ 6.3%, the sensitivity, specificity, and the discriminant ability,
were comparable between this study and that of Abu Dhabi (65.6%,
94.5%, 80% compared to 72.0%, 84.3%%, 78%, respectively). The
lower percentage of subjects diagnosed with diabetes by HbA1c
between this study and that of the Abu Dhabi study (8.2% vs.
21.0%, respectively) was not surprising since the prevalence of
diabetes in the UAE (25% in UEA citizens, and 20% in UAE) is the
second highest in the world [26] and subjects at high risk (HbA1c$
6.1%, 43 mmol/mol, and obese with mean BMI 30.4 kg/m2) were
chosen in the Abu Dhabi study. The slight difference in cut-off
values between the two studies could be due to the difference in
reference methods used to diagnose diabetes (FPG in this study vs.
OGTT in Abu Dhabi study) or the variability within the Arab
ethnicity. The study on Arabs living in the United States reported an
HbA1c cut-off value of 6.2% [24], but it is not clear from the study if
the Arabs were from the same origin. Since true negatives are
valued higher than true positives according to the recommendations
of the International Expert Committee [3], a cut-off value of $
6.5% (48 mmol/mol) with high specificity (97.1) and a reasonable
sensitivity (57.4%) is recommended instead of the cut-off value of
6.3% (45 mmol/mol). At this cut-off value ($ 6.5%, 48 mmol/
mol), HbA1c correctly diagnosed 57.4% as having diabetes and
57.3% as having prediabetes from those diagnosed by FPG. These
values are higher than those reported by Pinelli et al. [24] for Arabs
in the United States at the recommended cut-off value of $ 6.5%
(19% for diabetes, 14% for prediabetes). No values were reported
for prediabetes in the Abu Dhabi Arab study [25], however, a
previous study reported 5% in men and 7% in women having IFG
compared to 24.6% in this study [26].
More subjects were diagnosed as having diabetes and prediabetes
using HbA1c cut-off value of $ 6.5% (48 mmol/mol) for diabetes
and 5.7–6.4% (39–46 mmol/mol) for prediabetes (5.3% and 45.8%,
respectively) compared to FPG (4.5% and 24.6%, respectively).
When comparing FPG ($ 126 mg/dL,$ 7.0 mmol/L) and HbA1c
($ 6.5%, 48 mmol/L) to diagnose diabetes HbA1c diagnosed 73
subjects compared to 61 subjects by FPG from a total of 1370
subjects 35 subjects where identified by bothmethods. This indicated
a bad agreement between the two methods to recognize the same
diabetic subjects. This was also the case in prediabetes where HbA1c
diagnosed 628 and FPG 337 subjects from a total of 1370 subjects,
only 193 were diagnosed by both methods which indicated that the
two methods recognize different populations. Most previous studies
reported HbA1c to diagnose less subjects with diabetes compared to
FPG or OGTT [4,27,28]. This could be due to the delay in analysis
that affected FPG due to glycolysis more than HbA1c since samples
are transported to a central laboratory [18]. Other studies still
reported higher percentages of detecting undiagnosed diabetes by
HbA1c $ 6.5% (48 mmol/mol) compared to FPG $ 126 mg/dl
[29–31]. Diagnosing higher percentages of prediabetes using HbA1c
compared to FPG from this study is consistent with most previously
published reports [18,30,32].
Correlation between HbA1c $ 6.5% and diabetes as diagnosed
by FPG was moderate (K=0.498). This is consistent with recent
studies on Korean subjects (K=0.5) reported by Seo and Lee [33]
and Peru subjects (K=0.41) reported by Miranda et al. [31].
Table 3. Characteristics of individuals participating in the study according to HbA1c, FPG or both.
Parameter HbA1c FPG HbA1c and FPG
Nondiabetic Diabetic Nondiabetic Diabetic Nondiabetic Diabetic
Sex Male 450 (34.0%) 25 (34.2%) 443 (33.8%) 25 (41.0%) 432 (34.0%) 14 (40.0%)
Female 873 (66.0%) 48 (65.8%) 869 (66.2%) 36 (59.0%) 839 (66.0%) 21 (60.0%)
Diastolic BP (mm
Hg)
# 80 mm Hg 120 (94.2%) 65 (89.0%) 1226 (94.0%) 56 (91.8%) 1192 (94.3%) 33 (94.3%)
. 80 mm Hg 76 (5.8%) 8 (11.0%) 78 (6.0%) 5 (8.2%) 72 (5.7%) 2 (5.7%)
Systolic BP (mm Hg)# 120 mm Hg 1252 (95.1%) 65 (89.0%) 1240 (95.1%) 55 (90.2%) 1206 (95.4%) 33 (94.3%)
. 120 mm Hg 64 (4.9%) 8 (11.0%) 64 (4.9%) 6 (9.8%) 58 (4.6%) 2 (5.7%)
Family History for
Diabetes
Yes 730 (56.2%) 38 (62.3%) 727 (55.5%) 53 (72.6%) 69 (55.3%) 21 (60.0%)
No 568 (43.8%) 23 (37.7%) 583 (44.5%) 20 (27.4%) 562 (4 4.7%) 14 (40.0%)
TC (mmol/L) , 5.5 mm Hg 1101 (84.5%) 52 (71.2%) 1109 (84.6%) 40 (65.6%) 1081 (85.1%) 26 (74.3%)
$ 5.5 mm Hg 202 (15.5%) 21 (28.8%) 202 (15.4%) 21 (34.4%) 189 (14.9%) 9 (25.7%)
TG (mmol/L){ , 2.0 mmol/L 1112 (85.4%) 53 (72.6%) 1128 (86.1%) 33 (54.1%) 1096 (86.4%) 24 (68.6%)
$ 2.0 mmol/L 190 (14.6%) 20 (27.4%) 182 (13.9%) 28 (45.9%) 173 (13.6%) 11 (31.4%)
HDL (mmol/L) , 1.0 mmol/L 829 (63.5%) 50 (68.5%) 839 (63.9%) 38 (62.3%) 811 (63.8%) 25 (71.4%)
$ 1.0 mmol/L 475 (36.4%) 23 (31.5%) 473 (36.1%) 23 (37.7%) 460 (36.2%) 10 (28.6%)
LDL (mmol/L) , 3.5 mmol/L 954 (73.7%) 44 (60.3%) 956 (73.3%) 38 (63.3%) 934 (74.0%) 24 (68.6%)
$ 3.5 mmol/L 341 (26.3%) 29 (39.7%) 348 (26.7%) 22 (36.7%) 329 (26.0%) 11 (31.4%)
BMI , 25 216 (16.5%) 4 (5.6%) 214 (16.5%) 2 (3.4%) 211 (16.7%) 2 (5.7%)
25 – , 30 496 (37.9%) 19 (26.8%) 487 (37.5%) 19 (32.8%) 478 (37.9%) 11 (31.4%)
$ 30 597 (45.6%) 48 (67.6%) 597 (46.0%) 37 (63.8%) 571 (45.3%) 22 (62.9%)
{p= 0.013 between diabetic subjects diagnosed by HbA1c, FPG, and HbA1c+FPG.
Diabetic [HbA1c $ 6.5%, FPG $ 126 mg/dL ($ 7.0 mmol/L)]; Nondiabetic [HbA1c , 6.5%, FPG , 126 mg/dL (, 7.0 mmol/L)].
doi:10.1371/journal.pone.0088123.t003
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However Cavagnolli et al. [27] and Pinelli at al. [24] reported
poor correlation (K=0.217 and 0.2835, respectively). Not surpris-
ingly, both studies reported low sensitivity for HbA1c $ 6.5%
(20.9% and 19%, respectively) compared to this study and most
other studies that reported sensitivity close to 60%
[15,25,30,34,35]. The above two studies with poor correlation
and low sensitivity could be due to the study subjects with mixed
ethnicity (Arabs in the United States and Southern Brazilians).
The lack of effect of age, sex and BMI on the diagnostic criteria
of HbA1c as compared to FPG is consistent with previous studies
[20,24,36]. Age-stratified analysis on the feasibility of using HbA1c
to diagnose diabetes and prediabetes are consistent with the
findings of Penelli et al. [24]. Identifying subjects with diabetes by
HbA1c was not affected by age. However, the sensitivity for
detecting prediabetes in individuals aged 40–49 years (33.2%) or
50–59 years (37.5%) was significantly higher than those aged 30–
39 years (17.1%) (data not shown). There was no difference in the
number of subjects with high risk for diabetes and cardiovascular
disease diagnosed by HbA1c or FPG except for the parameter TG.
This indicates no serious disagreement between the two methods
to identify high risk people for diabetes and cardiovascular disease.
The diversity within the Arab ethnic groups requires more
studies on using HbA1c to accurately estimate the cut-off values
for diagnosing diabetes in different populations. In the Palestinian
Arab population raising the cut-off value to 6.5% (48 mmol/mol)
increases the percentage of subjects that require preventive
measures instead of treatment.
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